Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2009, p. 2194-2199, Vol. 47, No. 7
0095-1137/09/$08.00+0 doi:10.1128/JCM.01264-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

D. Paraskevis,
C. Haida,
V. Sypsa, and
A. Hatzakis*
Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece
Received 4 July 2008/ Returned for modification 17 January 2009/ Accepted 27 April 2009
Previous studies showed that high levels of human immunodeficiency virus type 1 (HIV-1) DNA are associated with a faster progression to AIDS, an increased risk of death, and a higher risk of HIV RNA rebound in patients on highly active antiretroviral therapy. Our objective was to develop and assess a highly sensitive real-time multiplex PCR assay for the quantification of HIV-1 DNA (RTMP-HIV) based on molecular beacons. HIV-1 DNA quantification was carried out by RTMP in a LightCycler 2.0 apparatus. HIV-1 DNA was quantified in parallel with CCR5 as a reference gene, and reported values are numbers of HIV-1 DNA copies/106 peripheral blood mononuclear cells (PBMCs). The clinical sensitivity of the assay was assessed for 115 newly diagnosed HIV-1-infected individuals. The analytical sensitivity was estimated to be 12.5 copies of HIV-1 DNA per 106 PBMCs, while the clinical sensitivity was 100%, with levels ranging from 1.23 to 4.25 log10 HIV-1 DNA copies/106 PBMCs. In conclusion, we developed and assessed a new RTMP-HIV assay based on molecular beacons, using a LightCycler 2.0 instrument. This multiplex assay has comparable sensitivity, reproducibility, and accuracy to single real-time PCR assays.
Published ahead of print on 6 May 2009.
The first two authors contributed equally to this work.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»